A brief application for a new drug for Lochatan potassium tablets filed by Haizheng Pharmaceuticals to the U.S. FDA has been approved
-
Last Update: 2020-06-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
recently, Haizheng Pharmaceuticals announced that the
holding company(http://Haizheng Pharmaceutical (Hangzhou) Co., Ltd("Haizheng Hangzhou Company") received a notice from the U.SFoodMedicines(http://Regulatory Authority (hereinafter referred to as the "U.SFDA(http://" notice, Haizheng Hangzhou The Company'sNew Drug(http://Application for theof The Loshatan Potassium Tablets filed with the U.SFDA, which is a u.S Pharmaceutical (http:// , and the application for FDA approval means that the applicant can produce and sell the product (http:// ) in the U.S market About Losatan potassium tablets
Losatan potassium tablets are mainly suitable for the treatment of hypertension, type 2 diabetes kidney disease Cozaar, the original research drug, was developed by Merck, and domestic and foreign manufacturers are mainly Zhejiang Huahai Pharmaceutical Co., Ltd., China Resources Shuanghe Pharmaceutical Co., Ltd., Beijing Shuangji Pharmaceutical Co., Ltd So far, Haizheng Pharmaceuticals has invested about 6.8 million yuan in the drug research and development project The approval of the Losatan potash tablet ANDA by the U.S FDA marks the company's eligibility to sell the product in the U.S market, which has a positive impact on the company's expansion into the U.S market
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
